Financials
- Market Capitalization 1.15 B
- Employee 113
- Founded 2017
- CEO N/A
- Website www.januxrx.com
- Headquarter Delaware, United States
- FIGI BBG00ZHSKH11
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.37
ratio cours/chiffre d'affaires
40.01
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2330 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.18 USD | +1.00% | -2.61% | +7.67% | +149.21% | 1.19 B USD | ||
| 2338 | ALMS Alumis Inc. - Common Stock | 9.13 USD | -58.14% | -61.38% | -67.03% | +102.44% | 1.18 B USD | ||
| 2361 | SANA Sana Biotechnology, Inc. - Common Stock | 3.84 USD | -0.78% | -6.57% | +22.29% | +27.57% | 1.15 B USD | ||
| 2364 | KURA Kura Oncology, Inc. - Common Stock | 12.85 USD | +1.58% | -6.14% | +42.46% | +60.83% | 1.14 B USD |